Our research on prostate cancer

Prostate cancer is the most common cancer in UK men but over two thirds of patients will now survive for at least 10 years. We are at the heart of this progress, and treatments continue to improve. 

Help us beat cancer sooner

We receive no government funding for our research. Our life-saving work relies on the money you give us.

Find out how you can support us


A pioneering new delivery system

Dr Helen McCarthy is creating a specialist nanoparticle delivery system for targeted gene therapy in patients with advanced breast or prostate cancer which has spread to the bones.

New hope for advanced prostate cancer

Our researchers helped to discover abiraterone (Zytiga), which is changing the outlook for men with prostate cancer.

Our strategy to beat cancer sooner

Our vision is to bring forward the day when all cancers are cured.Our new strategy will give us the foundations we need to tackle the challenges ahead.

More about prostate cancer

Find out about symptoms, risk factors and causes of prostate cancer and treatment on our Cancer Help pages.

Read the latest statistics for prostate cancer.

Share this page